Dyslipidemia is a disruption in the amount of lipids in the blood.
A new review article provides valuable insights into how traditional and emerging cardiac-specific biomarkers and their associated cardiovascular disease (CVD) risk factors may help point to effective preventive interventions in high-risk obese populations starting at an early stage of disease development.
Dietary fiber has been found to reduce the risk of high blood pressure and type 2 diabetes in a study presented at the American College of Cardiology Middle East Conference 2019.
Heart disease, which was once an illness affecting adults, is now a major concern among children. In fact, many studies have shown that the risks of cardiovascular disease pile up since childhood, hence, starting to educate them about practicing a healthy lifestyle is crucial to prevent the development of chronic and potentially-fatal diseases in the future.
Evaluating body composition, especially appendicular muscle mass, can be an effective strategy for predicting longevity in people over 65 years of age, according to a study conducted by researchers at the University of São Paulo's Medical School in Brazil.
Fatty liver disease is often associated with alcoholism, but more than a third of Americans have fatty livers despite moderate or absent alcohol consumption.
A team of researchers at the Clemson University found that Cyp2b gene, which metabolizes endo and xenobiotics, may be linked to age-onset obesity and dyslipidemia, especially in males.
A study performed in Brazil by researchers from São Paulo State University suggests that overweight and obese adolescents have similar increased risks of developing heart disorders. The results of cardiovascular fitness tests with volunteers aged 10-17 were similar in both groups.
Plant-based diets are associated with a lower risk of heart failure in adults without known heart disease, while Southern diets consisting of more fried and processed foods and sweetened drinks are associated with greater risk, according to a study published in the Journal of the American College of Cardiology that looked at the association between five dietary patterns and risk of heart failure.
A new study appearing in the journal CHEST, published by Elsevier, may change the way we think about sleep disorders.
Liver cancer remains a major problem in healthcare globally, being the second most common cause of cancer-related death globally.
As a raft of new treatments for HIV infection have come on the market in the past 20 years, AIDS patients got access to drugs that allowed them to live longer.
Meat-free athletes--from tennis champion Venus Williams to Formula 1's Lewis Hamilton to Derrick Morgan of the NFL's Tennessee Titans--have already proven the performance-boosting power of a plant-based diet.
Diets come and go and have their time in the trending list. The U.S. News and World Report has however confirmed that the healthiest diet at present is the Mediterranean diet.
Researchers from the UCLA Jonsson Comprehensive Cancer Center and the La Jolla Institute for Immunology have identified a new type of T cell called a phospholipid-reactive T cell that is able to recognize phospholipids, the molecules that help form cells' outer membranes.
A team led by a Cedars-Sinai physician-scientist has discovered a biomarker--a protein found in the blood--for the most common type of heart failure, a new study published today in JAMA Cardiology shows.
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.
A new study examined the relationship between fasting hyperglucagonemia -- which can negatively affect glucose metabolism in patients with type 2 diabetes -- and several biochemical and glycemic factors in subjects with T2D or in a nondiabetic control group.
People with type 1 diabetes are far more likely to develop cardiovascular disease than those without diabetes. Their risks climb even higher if they show signs of hypertension (high blood pressure) or dyslipidemia (unhealthy levels of cholesterol or triglycerides).
In obesity research, the body mass index has been traditionally used to determine if an individual is normal weight, underweight, overweight or obese. However, BMI does not differentiate between the types of the mass (fat or muscle) or body shapes.
Weight loss pills have been discovered and then withdrawn from the market because of the risks that they pose to the heart. Some of them have raised the risk of heart attacks, suicides, heart valve problems significantly and have been thus banned.